Sign in

Trial site

Osaka Prefectural Hospital Organization - Osaka International Cancer Institute

Osaka, Osaka 541-8567, JapanNot linked to an institution yet
  • 15running trials
  • 3closed trials

The trials here

What the 18 trials at this site are about, from their registry records.

Phase
  • Phase 313 trials
  • Phase 2/33 trials
  • Phase 11 trial
  • Phase 21 trial
Status
  • Active, not recruiting8 trials
  • Recruiting7 trials
  • Completed3 trials
Lead sponsor
  • BioNTech SE2 trials
  • Pfizer2 trials
  • Seagen, a wholly owned subsidiary of Pfizer2 trials
  • Taiho Oncology, Inc.2 trials
  • ADC Therapeutics S.A.1 trial
  • and 9 more

Running trials

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Closed trials

Site data: ClinicalTrials.govUpdated 12 Nov 2026